Pulmonary neuroendocrine (carcinoid) tumors: European Neuroendocrine Tumor Society expert consensus and recommendations for best practice for typical and atypical pulmonary carcinoidsM. Caplin, Zeng Zheng-Pei, D.K. Bartsch et al.|Annals of Oncology|2015Cited by 698
ENETS Consensus Guidelines for the Standards of Care in Neuroendocrine Tumors: Radiological, Nuclear Medicine and Hybrid ImagingAnders Sundin, Rudolf Arnold, Éric Baudin et al.|Neuroendocrinology|2017Cited by 495
European Society of Gynaecologic Oncology Quality Indicators for Advanced Ovarian Cancer SurgeryDenis Querleu, Andreas du Bois, François Planchamp et al.|International Journal of Gynecological Cancer|2016Cited by 141
Anti-tumour activity of a first-in-class agent NUC-1031 in patients with advanced cancer: results of a phase I studySarah P. Blagden, Essam Ghazaly, Ivana Rizzuto et al.|British Journal of Cancer|2018Cited by 43
Final results of ProGem1, the first in-human phase I/II study of NUC-1031 in patients with solid malignancies.Sarah P. Blagden, Christopher McGuigan, Ivana Rizzuto et al.|Journal of Clinical Oncology|2015Cited by 7